Marksans Pharma grants 400,000 employee stock options

Marksans Pharma Ltd. announced on September 24, 2025, that its nomination and remuneration committee approved the grant of 400,000 stock options to eligible employees and its subsidiaries. This grant is made under the 'Marksans Employees Stock Option Scheme 2024,' following special resolutions passed by shareholders and in-principle approvals from BSE Limited and National Stock Exchange of India Limited.

The stock options have an exercise price of INR 10 per stock option, covering 400,000 equity shares of face value INR 1 each, fully paid-up. The scheme complies with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Key terms include a one-year vesting period from the date of grant. Once vested, option grantees are entitled to acquire an equal number of equity shares upon payment of the full exercise price and applicable taxes. The exercise period for vested options is two years from the date of grant.